Large-scale testing (Phase 3)Looking for participantsNCT05674552What this trial is testingExogenous Ketone Esters for Refractory Status EpilepticsWho this might be right forStatus Epilepticus Sohag University 50
Post-approval studies (Phase 4)Not Yet RecruitingNCT07177235What this trial is testingKetamine for the Treatment of Refractory Status EpilepticusWho this might be right forRefractory Status Epilepticus Thomas Jefferson University 50
Post-approval studies (Phase 4)Ended earlyNCT05684978What this trial is testingEfficacy and Safety of Perampanel in the Treatment of Refractory Status EpilepticusWho this might be right forRefractory Status Epilepticus Wayne State University 1
Post-approval studies (Phase 4)Ended earlyNCT00215215What this trial is testingEffectiveness Study Comparing Treatment With Drug(s) or Adjunctive VNS Therapy for Pharmacoresistant Partial SeizuresWho this might be right forEpilepsies, Partial Cyberonics, Inc. 360
Large-scale testing (Phase 3)Study completedNCT01142193What this trial is testingStudy to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset SeizuresWho this might be right forEpilepsy Upsher-Smith Laboratories 249
Large-scale testing (Phase 3)Not Yet RecruitingNCT07281027What this trial is testingCOMparison Between Anakinra and Tocilizumab in NORSE - "COMBAT-NORSE"Who this might be right forNew Onset Refractory Status EpilepticusNew-Onset Refractory Status EpilepticusFebrile Infection-Related Epilepsy Syndrome (FIRES) Yale University 438
Large-scale testing (Phase 3)Study completedNCT00368069What this trial is testingLook at the Efficacy and Safety of Keppra® Extended Release Formulation - XRWho this might be right forEpilepsy UCB Pharma 158
Large-scale testing (Phase 3)Ended earlyNCT00265616What this trial is testingTreatment of Refractory Status EpilepticusWho this might be right forStatus Epilepticus Brigham and Women's Hospital 23
Not applicableLooking for participantsNCT04170491What this trial is testingEEG Monitoring for Refractory Status EpilepticusWho this might be right forStatus Epilepticus Barts & The London NHS Trust 40
Testing effectiveness (Phase 2)Ended earlyNCT01545518What this trial is testingIVIG Treatment for Refractory Immune-Related Adult EpilepsyWho this might be right forEpilepsy, CryptogenicEpilepsy, PartialSeizure Disorder+2 more Emory University 20
Not applicableLooking for participantsNCT06545643What this trial is testingSleep-Sensitive Seizure Risk Assessment With Wearable EEGsWho this might be right forEpilepsy Intractable Duke University 35
Large-scale testing (Phase 3)WithdrawnNCT04558580What this trial is testingSafety Study of Rufinamide Given as an add-on Therapy to Treat Patients With SeizuresWho this might be right forRefractory Partial Seizures University of South Alabama
Testing effectiveness (Phase 2)Looking for participantsNCT05851391What this trial is testingBuRst-supprESsion TO Stop Refractory Status Epilepticus Post-cardiac ArrestWho this might be right forHypoxia-Ischemia, BrainHeart ArrestStatus Epilepticus+4 more University of California, San Francisco 30
Testing effectiveness (Phase 2)Study completedNCT00903786What this trial is testingA Long-term Extension Study of E2007 in Patients With Refractory Partial Seizures Uncontrolled With Other Anti-Epileptic Drugs (AEDs)Who this might be right forRefractory Partial Seizures Eisai Co., Ltd. 21
Not applicableStudy completedNCT01281293What this trial is testingVagus Nerve Stimulation Clinical Outcomes Measured Prospectively in Patients StimulatedWho this might be right forEpilepsy Cyberonics, Inc. 124
Large-scale testing (Phase 3)Study completedNCT00957684What this trial is testingEfficacy and Safety of Eslicarbazepine Acetate as Adjunctive Therapy for Refractory Partial SeizuresWho this might be right forRefractory Partial Epilepsy Bial - Portela C S.A. 402
Testing effectiveness (Phase 2)Study completedNCT00152503What this trial is testingStudy With Subjects 18-65 Years Old With Partial Onset Seizures Who Are Currently Taking LevetiracetamWho this might be right forEpilepsy, Partial UCB Pharma SA 59
Not applicableUnknownNCT05248269What this trial is testingThermocoagulation in Drug Resistant Focal EpilepsyWho this might be right forEpilepsySeizures, FocalEpilepsy Intractable+1 more State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia 75
Large-scale testing (Phase 3)Ended earlyNCT00524134What this trial is testingP-glycoprotein Inhibition as Adjunct Treatment for Medically Refractory Epilepsy.Who this might be right forEpilepsy Columbia University 6
Testing effectiveness (Phase 2)Looking for participantsNCT07219407What this trial is testingA Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset SeizuresWho this might be right forFocal EpilepsyEpilepsyRefractory Focal Epilepsy+3 more Rapport Therapeutics Inc. 30